Clinical decision support systems for maternity care: a systematic review and meta-analysis.

Clinical decision support Maternity Obstetrics Systematic review mHealth

Journal

EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 16 03 2024
revised: 17 08 2024
accepted: 23 08 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 19 9 2024
Statut: epublish

Résumé

The use of Clinical Decision Support Systems (CDSS) is increasing throughout healthcare and may be able to improve safety and outcomes in maternity care, but maternity care has key differences to other disciplines that complicate the use of CDSS. We aimed to identify evaluated CDSS and synthesise evidence of their impact on maternity care. We conducted a systematic review for articles published before 24th May 2024 that described i) CDSS that ii) investigated the impact of their use iii) in maternity settings. Medline, CINAHL, CENTRAL and HMIC were searched for articles relating to evaluations of CDSS in maternity settings, with forward- and backward-citation tracing conducted for included articles. Risk of bias was assessed using the Mixed Methods Assessment Tool, and CDSS were described according to the clinical problem, purpose, design, and technical environment. Quantitative results from articles reporting appropriate data were meta-analysed to estimate odds of a CDSS achieving its desired outcome using a multi-level random effects model, first by individual CDSS and then across all CDSS. PROSPERO ID: CRD42022348157. We screened 12,039 papers and included 87 articles describing 47 unique CDSS. 24 articles (28%) described randomised controlled trials, 30 (34%) described non-randomised interventional studies, 10 (11%) described mixed methods studies, 10 (11%) described qualitative studies, 7 (8%) described quantitative descriptive studies, and 7 (8%) described economic evaluations. 49 (56%) were in High-Income Countries and 38 (44%) in Low- and Middle-Income countries, with no CDSS trialled in both income categories. Meta-analysis of 35 included studies found an odds ratio for improved outcomes of 1.69 (95% confidence interval 1.24-2.30). There was substantial variation in effects, aims, CDSS types, context, study designs, and outcomes. Most CDSS evaluations showed improvements in outcomes, but there was heterogeneity in all aspects of design and evaluation of systems. CDSS are increasingly important in delivering healthcare, and Electronic Health Records and mHealth will increase their availability, but traditional epidemiological methods may be limited in guiding design and demonstrating effectiveness due to rapid CDSS development lifecycles and the complex systems in which they are embedded. Development methods that are attentive to context, such as Human Centred Design, will help to meet this need. None.

Sections du résumé

Background UNASSIGNED
The use of Clinical Decision Support Systems (CDSS) is increasing throughout healthcare and may be able to improve safety and outcomes in maternity care, but maternity care has key differences to other disciplines that complicate the use of CDSS. We aimed to identify evaluated CDSS and synthesise evidence of their impact on maternity care.
Methods UNASSIGNED
We conducted a systematic review for articles published before 24th May 2024 that described i) CDSS that ii) investigated the impact of their use iii) in maternity settings. Medline, CINAHL, CENTRAL and HMIC were searched for articles relating to evaluations of CDSS in maternity settings, with forward- and backward-citation tracing conducted for included articles. Risk of bias was assessed using the Mixed Methods Assessment Tool, and CDSS were described according to the clinical problem, purpose, design, and technical environment. Quantitative results from articles reporting appropriate data were meta-analysed to estimate odds of a CDSS achieving its desired outcome using a multi-level random effects model, first by individual CDSS and then across all CDSS. PROSPERO ID: CRD42022348157.
Findings UNASSIGNED
We screened 12,039 papers and included 87 articles describing 47 unique CDSS. 24 articles (28%) described randomised controlled trials, 30 (34%) described non-randomised interventional studies, 10 (11%) described mixed methods studies, 10 (11%) described qualitative studies, 7 (8%) described quantitative descriptive studies, and 7 (8%) described economic evaluations. 49 (56%) were in High-Income Countries and 38 (44%) in Low- and Middle-Income countries, with no CDSS trialled in both income categories. Meta-analysis of 35 included studies found an odds ratio for improved outcomes of 1.69 (95% confidence interval 1.24-2.30). There was substantial variation in effects, aims, CDSS types, context, study designs, and outcomes.
Interpretation UNASSIGNED
Most CDSS evaluations showed improvements in outcomes, but there was heterogeneity in all aspects of design and evaluation of systems. CDSS are increasingly important in delivering healthcare, and Electronic Health Records and mHealth will increase their availability, but traditional epidemiological methods may be limited in guiding design and demonstrating effectiveness due to rapid CDSS development lifecycles and the complex systems in which they are embedded. Development methods that are attentive to context, such as Human Centred Design, will help to meet this need.
Funding UNASSIGNED
None.

Identifiants

pubmed: 39296586
doi: 10.1016/j.eclinm.2024.102822
pii: S2589-5370(24)00401-2
pmc: PMC11408819
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102822

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

WPS is a council member Royal College of Obstetricians and Gynecologists. MS and KN are directors of OpenClinical CIC, a not-for-profit organisation that seeks to promote the use of Clinical Decision Support technologies. MS owns stock and received royalties from Deontics Ltd., a Clinical Decision Support company whose products are not included in the reviewed papers. JSC received grant and contract funding from National Institute for Health and Care Research, Youth Endowment Fund, College of Policing, University of Birmingham, Birmingham City Council, Home Office (UK). BT received grant and contract funding from NIHR and UKRI/MRC. KN received grant and contract funding from NIHR, UKRI/MRC, Kennedy Trust for Rheumatology Research, Health Data Research UK, Wellcome Trust, European Regional Development Fund, Institute for Global Innovation, Boehringer Ingelheim, Action Against Macular Degeneration Charity, Midlands Neuroscience Teaching and Development Funds, South Asian Health Foundation, Vifor Pharma, College of Police, and CSL Behring, and consulting fees from BI, Sanofi, CEGEDIM and MSD.

Auteurs

Neil Cockburn (N)

Department of Applied Health Sciences, University of Birmingham, Birmingham, United Kingdom.

Cristina Osborne (C)

Department of Applied Health Sciences, University of Birmingham, Birmingham, United Kingdom.

Supun Withana (S)

Department of Applied Health Sciences, University of Birmingham, Birmingham, United Kingdom.

Amy Elsmore (A)

Department of Obstetrics and Gynaecology, Shrewsbury and Telford Hospitals NHS Trust, Telford, United Kingdom.

Ramya Nanjappa (R)

Department of Obstetrics and Gynaecology, Shrewsbury and Telford Hospitals NHS Trust, Telford, United Kingdom.

Matthew South (M)

Department of Applied Health Sciences, University of Birmingham, Birmingham, United Kingdom.

William Parry-Smith (W)

Department of Obstetrics and Gynaecology, Shrewsbury and Telford Hospitals NHS Trust, Telford, United Kingdom.
Keele University, Keele, United Kingdom.

Beck Taylor (B)

Warwick Medical School, Warwick University, Coventry, United Kingdom.

Joht Singh Chandan (JS)

Department of Applied Health Sciences, University of Birmingham, Birmingham, United Kingdom.
Birmingham Health Partners, University of Birmingham, Birmingham, United Kingdom.

Krishnarajah Nirantharakumar (K)

Department of Applied Health Sciences, University of Birmingham, Birmingham, United Kingdom.

Classifications MeSH